Form 4 for GILD Gilead Sciences
Accepted 2022-05-03 00:00:00 ET · period of report 2022-05-03 · accession 0001127602-22-013122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-05-03 | 2022-05-03 | GILD | Lofton Kevin E | Dir | M - OptEx | — | +2,223 | 92.7K | +2% | — |
| D | 2022-05-03 | 2022-05-03 | GILD | Lofton Kevin E | Dir | M - OptEx | — | -2,223 | 9,830 | -18% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-03 | M | A | 2,223 | — | 92,748 | I By Trust | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) Includes 63,430 shares held in a Revocable Living Trust and 29,318 shares held in a Grantor Retained Annuity Trust. |
| 2 | Derivative | Restricted Stock Unit | 2022-05-03 | M | D | 2,223 | — | 9,830 | D | — · — to — | 2,223 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) 100% of the restricted stock units vested on May 3, 2022. |